Lévesque Sarah, Pol Jonathan G, Ferrere Gladys, Galluzzi Lorenzo, Zitvogel Laurence, Kroemer Guido
Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
INSERM, U1138, Paris, France.
Oncoimmunology. 2019 Apr 3;8(7):1591878. doi: 10.1080/2162402X.2019.1591878. eCollection 2019.
Dietary interventions have a profound impact on whole body metabolism, including oncometabolism (the metabolic features allowing cancer cells to proliferate) and immunometabolism (the catabolic and anabolic reactions that regulate immune responses). Recent preclinical studies demonstrated that multiple dietary changes can improve anticancer immunosurveillance of chemo-, radio- and immunotherapy. These findings have fostered the design of clinical trials evaluating the capacity of dietary interventions to synergize with treatment and hence limit tumor progression. Here, we discuss the scientific rationale for harnessing dietary interventions to improve the efficacy of anticancer therapy and present up-to-date information on clinical trials currently investigating this possibility.
饮食干预对全身代谢有深远影响,包括肿瘤代谢(使癌细胞得以增殖的代谢特征)和免疫代谢(调节免疫反应的分解代谢和合成代谢反应)。最近的临床前研究表明,多种饮食改变可改善化疗、放疗和免疫疗法的抗癌免疫监视。这些发现推动了临床试验的设计,以评估饮食干预与治疗协同作用从而限制肿瘤进展的能力。在此,我们讨论利用饮食干预提高抗癌治疗疗效的科学依据,并提供目前正在研究这种可能性的临床试验的最新信息。